Risk Factors and Markers Associated With Proliterative Retinopathy in Patients With Insulin-Dependent Diabetes
暂无分享,去创建一个
L. Groop | P. Groop | E. Matikainen | A. Teppo | E. Tolppanen | S. Koskimies | H. Teir | E. Verkkala | T. Scheinin | S. Kontiainen | L. Tallgren
[1] L. Groop,et al. Urinary Excretion of Plasma Proteins in Diabetic Subjects: Increased Excretion of Kappa Light Chains in Diabetic Patients With and Without Proliferative Retinopathy , 1985, Diabetes.
[2] A. Fauci,et al. Abnormalities of immunoregulatory T cell subsets in patients with insulin-dependent diabetes mellitus. , 1982, Journal of Immunology.
[3] O. Andersen. Anti-insulin-antibodies and late diabetic complications. , 1976, Acta endocrinologica.
[4] J. Rygaard,et al. Suppressor cell activity in patients with newly diagnosed insulin-dependent diabetes mellitus: a prospective study. , 1982, Journal of clinical & laboratory immunology.
[5] D. Lezotte,et al. Limited joint mobility in childhood diabetes mellitus indicates increased risk for microvascular disease. , 1981, The New England journal of medicine.
[6] H. Keen,et al. The Patterns of Proteinuria in Diabetes Mellitus: Relevance to Pathogenesis and Prevention of Diabetic Nephropathy , 1984, Diabetes.
[7] L. Groop,et al. Proliferative responses to insulin antigens in diabetics and controls. , 1983, Journal of clinical & laboratory immunology.
[8] E. Kohner,et al. Genetic and Immunologic Factors in Microvascular Disease in Type I Insulin-Dependent Diabetes , 1982, Diabetes.
[9] J. Colwell. Effect of Diabetic Control on Retinopathy , 1966, Diabetes.
[10] K. Woods,et al. IMMUNE COMPLEXES IN DIABETIC RETINOPATHY , 1978, The Lancet.
[11] A. Salmi,et al. Evaluation of six tests for circulating IgG complexes with special reference to IgM rheumatoid factors: analysis of systemic lupus erythematosus and rheumatoid arthritis series. , 1981, Clinical and experimental immunology.
[12] K. Guy,et al. The correlation between insulin antibodies and circulating immune complexes in diabetics with and without microangiopathy. , 1983, Clinical and experimental immunology.
[13] R. Schifman,et al. Cholesterol in high-density lipoprotein: use of Mg2+/dextran sulfate in its enzymic measurement. , 1978, Clinical chemistry.
[14] J H Dobree,et al. Simple diabetic retinopathy. Evolution of the lesions and therapeutic considerations. , 1970, The British journal of ophthalmology.
[15] D. Johnston,et al. SEVERE RETINOPATHY AND MILD CARBOHYDRATE INTOLERANCE: POSSIBLE ROLE OF INSULIN DEFICIENCY AND ELEVATED CIRCULATING GROWTH HORMONE , 1985, The Lancet.
[16] K. Lundbaek,et al. TYPES OF EXUDATES IN DIABETIC RETINOPATHY. , 2009 .
[17] D. DeMets,et al. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. , 1984, Archives of ophthalmology.
[18] Clinical Predictors of Retinopathy and Its Progression in Patients with Type I Diabetes During CSII or Conventional Insulin Treatment , 1985, Diabetes.
[19] D. Pyke,et al. Diabetic Retinopathy in Identical Twins , 1982, Diabetes.
[20] L. Groop,et al. HLA-types and insulin responses in insulin dependent diabetics with or without proliferative retinopathy , 1985 .
[21] K. Guy,et al. Immune complexes and diabetic microangiopathy. , 1978, Journal of clinical & laboratory immunology.
[22] G. Forlani,et al. Lipid Abnormalities in Insulin-dependent Diabetic Patients with Albuminuria , 1984, Diabetes Care.